You searched for "Cell"

2310 results found

Patient initiated follow-up in head and neck cancer

Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

Innovative approaches to treating deafness

Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...

The role of objective measures and imaging to optimise cochlear implant outcomes

Should we be using new or novel objective measures and imaging to assist with our cochlear implant patients? Debi Vickers and Shak Saeed describe current clinical techniques and present advances that have the potential to optimise outcomes. Introduction It is...

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...

In conversation with Professor David Kemp

Ted Killan, Vice-Chair of the British Society of Audiology (BSA), caught up with Professor Kemp to discuss his scientific journey over the past 40 years, and what we can expect from OAEs in the future. Prof David T Kemp. In...

Not just the scissors: the story of Myron Metzenbaum

Myron Metzenbaum was born in Cleveland, Ohio (USA) in 1876, the fourth of nine children. As a young man, he worked in the family’s linen store, where his father was well known to be very kind to the less fortunate...

Mind the gap – developing a sustainable pipeline for hearing therapeutics

In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...

International Federation of Head and Neck Oncologic Societies

IHNOS Head and Neck Cancer Summit

True Cut – a dramatic biopsy from the world of surgery

True Cut is a stage play that asks: “What happens when things go wrong in healthcare?” It brings the hidden world of the operating theatre onto the theatre stage. ENT surgeon, David Alderson, talks about how the play came about....

A shifting landscape of otitis media

In light of pneumococcal vaccination programmes, is otitis media evolving to have a different natural history? Acute otitis media (AOM) is a major public health problem in children worldwide, as it is the leading bacterial infection and first cause of...

In conversation with Dr Peter Belafsky

Dr Peter Belafsky. Peter – tell us about your background I was born in Philadelphia and went on to study at Vassar College which is a small liberal arts school in upstate New York. I then attended Medical School in...

A drug to prevent hearing loss caused by ototoxic therapeutics

This editorial briefly highlights the progress made in discovering a compound named ORC-13661, which shows the potential to alter the response of hair cells to ototoxic medication. In the late 1980s, inner hair cells that were lost secondary to noise...